Kim Boyd Receives Prestigious TIME Award from NCPDP
Kim Boyd honored for outstanding leadership and lasting contributions in the Healthcare Industry
In a remarkable recognition of her dedication to the healthcare realm, Kim Boyd, Principal at Leavitt Partners, has been awarded the 2025 TIME Award from the National Council for Prescription Drug Programs (NCPDP). As a respected member of the NCPDP Board of Trustees and Chair of the Strategic Planning Committee, Boyd's contributions have been influential in shaping the future of healthcare standards.
The TIME Award stands as NCPDP's highest member accolade, distinguishing individuals who have shown exceptional commitment to furthering the organization's objectives. Members nominate candidates, with the winner determined by a vote among the Board of Trustees.
During a special ceremony at the Annual Technology and Business Conference, NCPDP President and CEO, Lee Ann Stember, applauded all nominees. "Each of our nominees exemplifies the leadership, dedication, and collaborative spirit that move NCPDP and the healthcare industry forward," she remarked. This reflects the high caliber of leadership within the organization and the healthcare sector as a whole.
Boyd's extensive commitment to advancing NCPDP's goals has left an indelible mark, as pointed out by Stember: "Kim has devoted countless hours to our vision and mission. Her leadership as Chair of the Strategic Planning Committee and her ongoing contributions on the Board of Trustees hold profound significance." Boyd’s influence is evident in the way she has helped coordinate the strategic direction of NCPDP, enhancing their efforts within the healthcare landscape.
Moreover, Boyd played a pivotal role in the development of NCPDP’s new Strategic Plan. This plan continues to guide the organization's initiatives aimed at fostering innovation, advocacy, and collaboration across the healthcare field.
The 2025 TIME Award celebrates Boyd’s exceptional service and is proudly sponsored by NCPDP's Elite Partner, FDB (First Databank), which supports the ongoing pursuit of excellence in healthcare services.
About NCPDP
The National Council for Prescription Drug Programs, established in 1977, operates as a nonprofit ANSI-accredited Standards Developer with a diverse membership base within the healthcare industry. NCPDP is dedicated to developing standards and solutions that facilitate the efficient exchange of information related to medications, supplies, and services. This includes crucial initiatives like the SCRIPT Standard for ePrescribing and the Telecommunications Standard. Their data products, such as dataQ® and HCIdea®, offer vital insights and comprehensive databases that contribute significantly to healthcare operations.
NCPDP also provides RxReconn®, which tracks pharmacy-related legislative and regulatory activities at both state and national levels. Recognized in federal legislation, including HIPAA and HITECH, NCPDP has been at the forefront of promoting healthcare interoperability for many years. For further information, visit www.ncpdp.org.
Frequently Asked Questions
Who is Kim Boyd?
Kim Boyd is the Principal at Leavitt Partners and a notable member of the NCPDP Board of Trustees.
What is the TIME Award?
The TIME Award is the most prestigious member honor given by NCPDP, recognizing exceptional contributions to the organization's goals.
What are Kim Boyd’s contributions to NCPDP?
Boyd has contributed significantly as Chair of the Strategic Planning Committee and has been key in developing NCPDP's strategic initiatives.
Who presented the TIME Award?
The 2025 TIME Award was presented by NCPDP President and CEO Lee Ann Stember.
What is NCPDP's mission?
NCPDP's mission focuses on improving healthcare standards and facilitating the exchange of information regarding medications and services.
